These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6788058)

  • 1. Valproic acid fails to displace phenobarbitone and carbamazepine from plasma protein binding sites in epileptic patients.
    Pisani F; Oteri G; Di Perri R
    Br J Clin Pharmacol; 1981 Jul; 12(1):81-3. PubMed ID: 6788058
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital.
    Castro-Gago M; Novo-Rodríguez MI; Blanco-Barca MO; Urisarri-Ruíz de Cortázar A; Rodríguez-García J; Rodríguez-Segade S; Eirís-Puñal J
    J Child Neurol; 2006 Jan; 21(1):48-53. PubMed ID: 16551453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein binding interaction between valproic acid and phenobarbital in vitro.
    Yu HY; Shen YZ
    Taiwan Yi Xue Hui Za Zhi; 1982 Dec; 81(12):1482-91. PubMed ID: 6820381
    [No Abstract]   [Full Text] [Related]  

  • 4. Epilepsy and IgA deficiency--the effect of sodium valproate.
    Joubert PH; Aucamp AK; Potgieter GM; Verster F
    S Afr Med J; 1977 Oct; 52(16):642-4. PubMed ID: 337537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions.
    Dasgupta A; Volk A
    Ther Drug Monit; 1996 Jun; 18(3):284-7. PubMed ID: 8738769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in protein binding of drugs in plasma and serum.
    Ohshima T; Hasegawa T; Johno I; Kitazawa S
    Clin Chem; 1989 Aug; 35(8):1722-5. PubMed ID: 2503268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients.
    Shakir S; Ali N; Nazish H
    J Coll Physicians Surg Pak; 2018 May; 28(5):357-360. PubMed ID: 29690963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid and plasma levels of phenobarbital.
    Bruni J; Wilder BJ; Perchalski RJ; Hammond EJ; Villarreal HJ
    Neurology; 1980 Jan; 30(1):94-7. PubMed ID: 6985722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between valproic acid and carbamazepine: an in vitro study of protein binding.
    Mattson GF; Mattson RH; Cramer JA
    Ther Drug Monit; 1982; 4(2):181-4. PubMed ID: 6808714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination and stability of 4 therapeutic drugs collected into evacuated tubes with serum gel separator].
    Vigier JP; Guerber F; Pinel N
    Ann Biol Clin (Paris); 2000; 58(6):738-9. PubMed ID: 11098172
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum protein binding of antiepileptic drugs in Sri Lankans.
    Karunanayake EH; Joice PD; Peiris JB; Meijer JW; Meinardi H
    Ceylon Med J; 1990 Mar; 35(1):25-8. PubMed ID: 2361227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of sodium valproate, phenytoin and carbamazepine and seizure control in epilepsy.
    Goggin T; Casey C; Callaghan N
    Ir Med J; 1986 Jun; 79(6):150-6. PubMed ID: 3089966
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma levels of anticonvulsants. Experiences with routine plasma level determination of 6 different anticonvulsants].
    Klotz U
    Fortschr Med; 1978 Jan; 96(1):9-13. PubMed ID: 340366
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of total and free anticonvulsant serum levels in clinical practice.
    Beran RG; Lewis JH; Nolte JL; Westwood AP
    Clin Exp Neurol; 1985; 21():69-77. PubMed ID: 3939613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy].
    Avakian GN; Oleĭnikova OM; Lagutin IuV; Khromykh EA; Bogomazova MA; Delger AB; Avakian GG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):34-9. PubMed ID: 24429946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
    Prodam F; Bellone S; Casara G; De Rienzo F; Grassino EC; Bonsignori I; Demarchi I; Rapa A; Radetti G; Bona G
    Epilepsia; 2010 Feb; 51(2):312-5. PubMed ID: 19780793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium valproate and ethosuximide on phenobarbital plasma protein binding.
    Patsalos PN; Lascelles PT
    Neurology; 1982 Sep; 32(9):1052-3. PubMed ID: 6810205
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients.
    Zhang H; Zhang W; Li Y; Yan J; Zhang J; Wang B
    Brain Dev; 2018 Feb; 40(2):100-106. PubMed ID: 28958730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing plasma phenobarbitone levels in epileptic patients.
    Eadie MJ; Lander CM; Hooper WD; Tyrer JH
    Br J Clin Pharmacol; 1977 Oct; 4(5):541-7. PubMed ID: 911604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.